| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in EDIT over the last quarter tilts toward selling: insiders offloaded a net 6,964 shares worth roughly $21K.
EDIT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 243.2K | $738.6K | - | |
| VP | 61.7K | $187.3K | - | |
| CFO | 13.8K | $42.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Burkly Linda48 | EVP, Chief Scientific Officer | Sell | 726 | $1.72 | $1,251.84 | -1.0% | +35.7% | +52.7% | |
| Jun 3, 2025 | O'Neill Gilmore Neil69 | CEO | Sell | 15,192 | $1.72 | $26,195.57 | -5.1% | +35.7% | +52.7% | |
| Mar 4, 2025 | Lucera Erick | EVP, Chief Financial Officer | Sell | 4,109 | $1.71 | $7,029.68 | -3.5% | +0.6% | +25.0% | |
| Mar 4, 2025 | O'Neill Gilmore Neil69 | CEO | Sell | 16,632 | $1.71 | $28,452.36 | -5.3% | +0.6% | +25.0% | |
| Mar 4, 2025 | Burkly Linda48 | EVP, Chief Scientific Officer | Sell | 2,891 | $1.71 | $4,945.63 | -4.0% | +0.6% | +25.0% | |
| Dec 3, 2024 | O'Neill Gilmore Neil69 | CEO | Sell | 1,618 | $2.08 | $3,361.23 | -0.5% | -10.6% | +19.4% | |
| Dec 3, 2024 | Mei Baisong77 | EVP, Chief Medical Officer | Sell | 541 | $2.08 | $1,123.77 | -0.4% | -10.6% | +19.4% | |
| Sep 4, 2024 | Mei Baisong77 | EVP, Chief Medical Officer | Sell | 518 | $3.42 | $1,773.99 | -0.4% | -43.4% | -28.0% | |
| Sep 4, 2024 | O'Neill Gilmore Neil69 | CEO | Sell | 1,555 | $3.42 | $5,325.41 | -0.5% | -43.4% | -28.0% | |
| Jul 25, 2024 | Burkly Linda48 | EVP, Chief Scientific Officer | Sell | 11,886 | $5.42 | $64,369.82 | -14.0% | -42.4% | -43.4% |